Download the white paper. Recombinant antibodies have revolutionized the field of research, offering a more specific, consistent, and high-quality alternative to traditional antibody development methods. ProSci offers a comprehensive suite of services for recombinant antibody…
Read More
Uncategorized
Single Domain Antibodies: Unlocking the Potential of Targeted Therapeutics
Antibodies are an essential immune system component and play a vital role in disease diagnosis and treatment. In recent years, breakthroughs in the development of single-domain antibodies (sdAbs) have opened new possibilities in biotechnology and…
Read More
Enhance your Research with ProSci’s Polyclonal Antibody Services
Enhance your Research with ProSci’s Polyclonal Antibody Services What are Polyclonal Antibodies? Download the white paper. Polyclonal antibodies are a mixture of antibodies from multiple B-cell clones of a host animal that can recognize multiple…
Read More
Maximizing Your Success with ProSci’s Custom Monoclonal Antibody Services
Maximizing Your Success with ProSci’s Custom Monoclonal Antibody Services – The monoclonal antibody market is expected to reach $524.68 billion by 2030. This highlights the growing demand for monoclonal antibodies in biomedical research, diagnostics, and…
Read More
Single Domain Antibodies
In this blog, ProSci will take you through the advantages of single domain antibodies—also known as Nanobodies™, VHH antibodies, and camelid antibodies—and the process ProSci uses to develop high-performing antibodies. Single Domain Antibodies (sdAbs) from…
Read More
